# FDA 483 - Sumitomo Dainippon Pharma Co., Ltd. - August 07, 2025

Source: https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/2bc62c0d-aa64-4304-8835-9affb19a6448

> FDA 483 for Sumitomo Dainippon Pharma Co., Ltd. on August 07, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2025-08-07
- Product Type: drugs
- Office Name: International Compliance Team
- Summary: An FDA inspection of Sumitomo Pharma Co., Ltd. in Suzuka, Japan, a drug manufacturer, revealed significant deficiencies in quality control. Observations included inadequate sampling procedures for raw materials, insufficient microbial control strategies for non-sterile drug products, and a failure to maintain complete backups of electronic data from visual inspection equipment. These issues indicate a need for improved quality systems to ensure product safety and data integrity.

## Related Documents

- [483 - 2019-11-22](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/1731dc44-1562-4b56-a1ab-11523c1ef33a)
- [483 - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/86a81dce-ec5c-4538-92d1-957b4b070918)
- [483 - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/86bec48e-adb4-4655-bc52-1a8046463dde)
- [483 - 2025-08-07](https://www.globalkeysolutions.net/records/483/sumitomo-dainippon-pharma-co-ltd/628e7814-ad3c-4132-bf5c-8987bf6047c2)

## Related Officers

- [ Drug Investigator](https://www.globalkeysolutions.net/people/tekalign-wondimu/3b80e5c8-4062-4e1d-8ddd-b1afa2616dec)

Company: https://www.globalkeysolutions.net/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

Office: https://www.globalkeysolutions.net/offices/international-compliance-team/f0ce0d89-bf39-46c6-8c42-28138d161321